Thermo Fisher Scientific’s PPD clinical research arm is significantly expanding its presence in Kentucky. The expansion entails a 65,000-square-foot facility in Covington, increasing the company’s laboratory footprint. This investment of $47.8 million will generate over 250 new positions in the region over the next eight years.
PPD has maintained a central laboratory operation in Highland Heights since 2002, offering biomarker operations, sample management, and testing for novel therapies. The Covington expansion will bolster these capabilities.
According to Leon Wyszkowski, president of Thermo Fisher’s analytical services division, the central laboratory is crucial in facilitating efficient clinical trial decisions and ensuring patient well-being. This expansion will enhance clients’ research and development initiatives.
Kentucky Governor Andy Beshear expressed enthusiasm for Thermo Fisher’s continued investment in the state, highlighting the growth in the healthcare and life sciences sectors. He anticipates the company’s success in the region and its positive impact on the local economy.
The Highland Heights laboratory employs over 600 professionals, including scientific and support staff, providing safety testing, clinical sample management, and biomarker support. Thermo Fisher’s clinical research business also operates additional laboratories internationally, including facilities in Belgium, Singapore, Virginia, Wisconsin, Ireland, and China.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
